Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome (PREVENT VILI)
PREcision VENTilation to Attenuate Ventilator-Induced Lung Injury: A Phase 3 Multicenter Randomized Clinical Trial
Sponsor: Beth Israel Deaconess Medical Center
A PHASE3 clinical study on Acute Respiratory Distress Syndrome and Respiratory Failure, this trial is actively recruiting participants. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 9 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Jun 2025 — Jul 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2024 — Mar 2024 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2023 — Jan 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Massachusetts General Hospital
- NYU Langone Health
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .